Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.
Trending
- Who Adopts AI First: Endoscopists or Humanoid Robots?
- Quest Diagnostics to offer liver cancer blood test (Becker’s GI & Endoscopy)
- Greater Scope: Doctors Get Inside Look at Gut Health With AI-Powered Endoscopy (NVIDIA)
- State of AI in Medicine (Doximity)
- Abbott Acquisition Of Exact Sciences Refocuses Growth On Cancer Diagnostics (Simply Wall Street)
- Will the ‘gestalt’ matter less in GI surgery? (Becker’s GI & Endoscopy)
- Advancing Multidisciplinary Strategies for Obesity Care (AJMC)
- 5 studies scaring gastroenterologists (Becker’s ASC Review)
